Skip to main content

Loading market data...

PM

Philip Morris International Inc.

NYSE • United states

$197.46

-$2.44

(-1.22%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Philip Morris International Inc. (PM)

Unavailable

Quotes may be delayed

$307.76B

Market Cap

5,768,726

Volume

28.3

P/E Ratio

3.04%

Div Yield

Philip Morris International Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 677 WASHINGTON BLVD, STE. 1100, STAMFORD, CT
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Philip Morris International Inc. reported Operating or financial results

Philip Morris International Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

18 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

8 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

8 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

24 Aug 2026

Philip Morris International Inc. reported Regulation FD disclosure

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$6.00B

Total assets (USD)$68.27B

Total liabilities (USD)$74.93B

Shareholders' equity (USD)−$8.58B

Long-term debt (USD)$15.35B

Debt due within a year (USD)$1.41B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$11.19B	$4.53B	$2.82B	$1.80	10-Q · 24 Jul 2026
Q1 2026	$10.15B	$3.89B	$2.44B	$1.56	10-Q · 24 Apr 2026
Q4 2025	$10.36B	$3.37B	$2.14B	Unavailable	10-K · 6 Feb 2026
Q3 2025	$10.85B	$4.26B	$3.48B	$2.23	10-Q · 24 Oct 2025
Q2 2025	$10.14B	$3.71B	$3.04B	$1.95	10-Q · 25 Jul 2025
Q1 2025	$9.30B	$3.54B	$2.69B	$1.72	10-Q · 24 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $210.11

6.4% upside potential

📈

Strong Buy

Unavailable

👍

Buy

8

⏸️

Hold

2

📉

Sell

0

10 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 05:48 UTC Targets range 175.00–225.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

6

May 2026

Combes Michel

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Geissler Werner

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Morparia Kalpana

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Harker Victoria D

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Polet Robert

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Bough Bonin

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Hook Lisa

Director

Grant or award

$169.93 per share

1,119 shares

6

May 2026

Calantzopoulos Andre

Director

Grant or award

$169.93 per share

1,119 shares

Top Shareholders

Vanguard Group Inc

145,262,397 shares

1.25% change

12/31/2025

Capital World Investors

133,152,391 shares

-0.223% change

6/30/2026

Blackrock, Inc.

108,039,522 shares

0.472% change

6/30/2026

Vanguard Capital Management Llc

101,785,557 shares

0.622% change

6/30/2026

Capital Research Global Investors

84,253,663 shares

5.551% change

6/30/2026

Capital International Investors

72,252,261 shares

-0.7% change

6/30/2026

State Street Corp

55,569,994 shares

0.976% change

6/30/2026

Jpmorgan Chase & Co

48,189,101 shares

-6.594% change

6/30/2026

Fmr Llc

46,521,326 shares

3.91% change

6/30/2026

Gqg Partners Llc

45,436,985 shares

-9.318% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 05:48 UTC· 45 minutes ago

Research coverage and investment tools

Philip Morris International Inc. (PM) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medicinal Chemicals and Botanical Products). Its last price was US$197.46 on 21 Oct 2026. That is 81% of the way from its 52-week low of US$142.11 to its 52-week high of US$210.45. It paid US$6.01 a share in dividends over the last 12 months, a dividend yield of 3.04%. The latest ex-dividend date on file is 2 Oct 2026. Its market capitalisation was US$307.76 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$11.19B	$4.53B	$2.82B	$1.80	68.4%	40.5%	$5.11B	10-Q · 24 Jul 2026 (opens in a new tab)
Q1 2026	$10.15B	$3.89B	$2.44B	$1.56	68.1%	38.4%	−$752.00M	10-Q · 24 Apr 2026 (opens in a new tab)
Q4 2025	$10.36B	$3.37B	$2.14B	Unavailable	65.6%	32.6%	$4.27B	10-K · 6 Feb 2026 (opens in a new tab)
Q3 2025	$10.85B	$4.26B	$3.48B	$2.23	67.8%	39.3%	$4.10B	10-Q · 24 Oct 2025 (opens in a new tab)
Q2 2025	$10.14B	$3.71B	$3.04B	$1.95	67.7%	36.6%	$3.06B	10-Q · 25 Jul 2025 (opens in a new tab)
Q1 2025	$9.30B	$3.54B	$2.69B	$1.72	67.4%	38.1%	−$754.00M	10-Q · 24 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/22/2026	$2.20	$2.04	+7.8%
Mar 2026	4/22/2026	$1.96	$1.82	+7.7%
Dec 2025	2/6/2026	$1.70	$1.67	+1.8%
Sep 2025	10/21/2025	$2.24	$2.10	+6.7%

Cash and equivalents: $6.00B
Total assets: $68.27B
Total liabilities: $74.93B
Shareholders' equity: −$8.58B
Long-term debt: $15.35B
Debt due within a year: $1.41B

8-K · 21 Oct 2026

Philip Morris International Inc. reported Operating or financial results (opens in a new tab)

Philip Morris International Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 18 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure (opens in a new tab)

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 8 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure (opens in a new tab)

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 8 Sep 2026

Philip Morris International Inc. reported Regulation FD disclosure (opens in a new tab)

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 24 Aug 2026

Philip Morris International Inc. reported Regulation FD disclosure (opens in a new tab)

Philip Morris International Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Combes Michel Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Geissler Werner Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Morparia Kalpana Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Harker Victoria D Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Polet Robert Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Bough Bonin Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Hook Lisa Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)
Calantzopoulos Andre Director	6 May 2026	Grant or award (A)	+1,119	$169.93	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	145,262,397	1.25%
Capital World Investors	6/30/2026	133,152,391	-0.223%
Blackrock, Inc.	6/30/2026	108,039,522	0.472%
Vanguard Capital Management Llc	6/30/2026	101,785,557	0.622%
Capital Research Global Investors	6/30/2026	84,253,663	5.551%
Capital International Investors	6/30/2026	72,252,261	-0.7%
State Street Corp	6/30/2026	55,569,994	0.976%
Jpmorgan Chase & Co	6/30/2026	48,189,101	-6.594%
Fmr Llc	6/30/2026	46,521,326	3.91%
Gqg Partners Llc	6/30/2026	45,436,985	-9.318%

Previous close: 199.90 USD
Day range: 184.00 – 197.83 USD
52-week range: 142.11 – 210.45 USD
Volume: 5,768,726
Market cap: $307.76B
Average volume: 4,500,493
P/E ratio: 28.3
EPS (FY 2025, diluted): 7.26 USD
Dividends (last 12 months): 6.01 USD
Dividend yield: 3.04%
Ex-dividend date: 2 Oct 2026
Shares outstanding: 1.56B
Beta (5Y monthly): 0.35

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 10 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:12 UTC· 20 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:12 UTC· 20 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for PM yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.